Replies to post #97431 on Biotech Values

[DewDiligence]

CRL’s and NDA/BLA withdrawals are not announced by the FDA.

[DewDiligence]

FDA panel rejects flibanserin by 11-0 and 10-1 votes on safety and efficacy, respectively:

http://www.reuters.com/article/idAFN1810529720100618

BPAX is essentially flat on the day.